
Allogene Therapeutics (NASDAQ:ALLO) is set to give its latest quarterly earnings report on Wednesday, 2022-02-23. Here's what investors need to know before the announcement.
Analysts estimate that Allogene Therapeutics will report an earnings per share (EPS) of $-0.60.